Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph phase_1
3
50%
Ph phase_2
2
33%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
Phase 41 (16.7%)

Trials by Status

completed467%
terminated117%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
unknownphase_2

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

NCT00052325
terminatedphase_1

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

NCT00049608
completedphase_4

RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

NCT01401075
completedphase_1

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

NCT00006354
completedphase_1

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

NCT00006477
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00052325Phase 2

Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy

Unknown
NCT00049608Phase 1

Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

Terminated
NCT01401075Phase 4

RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients

Completed
NCT00006354Phase 1

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Completed
NCT00006477Phase 1

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

Completed
NCT00516022Phase 2

Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.

Completed

All 6 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6